|1.||Thelen, Paul: 4 articles (11/2013 - 08/2005)|
|2.||Jung, Sang Hoon: 3 articles (11/2008 - 06/2002)|
|3.||Ringert, Rolf-Hermann: 3 articles (10/2007 - 08/2005)|
|4.||Spengler, Barbara: 3 articles (08/2005 - 12/2004)|
|5.||Christoffel, Volker: 3 articles (08/2005 - 12/2004)|
|6.||Schweyer, Stefan: 2 articles (11/2013 - 10/2007)|
|7.||Jiang, Chun-Ping: 2 articles (08/2012 - 04/2012)|
|8.||Wu, Jun-Hua: 2 articles (08/2012 - 04/2012)|
|9.||Shi, Da-Hua: 2 articles (08/2012 - 04/2012)|
|10.||Wang, Yu-Rong: 2 articles (08/2012 - 04/2012)|
|1.||Prostatic Neoplasms (Prostate Cancer)
03/05/2013 - "Among them, tectorigenin, possessing the highest anti-prostate cancer activity with IC₅₀ value of 0.08 μM, has priority to be lead compound. "
02/01/2006 - "Cultured androgen-sensitive LNCaP prostate cancer cells were treated with tectorigenin of 100 microM for 24 hours. "
08/01/2005 - "Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer."
07/01/2007 - "To investigate the changes in expression underlying the marked reduction of tumour growth in vivo, by analysing the effect of Belamcanda chinensis extract (BCE) on LNCaP cells in vitro, as phytoestrogens are chemopreventive in prostate cancer, and in previous studies we examined the effects of the isoflavone tectorigenin isolated from B. "
12/01/2004 - "These in vitro studies demonstrate a role for tectorigenin and irigenin in regulating prostate cancer cell number by inhibiting proliferation through cell cycle regulation."
|2.||Liver Cirrhosis (Hepatic Cirrhosis)
08/01/2012 - "The aim of this study was to investigate the effects of tectorigenin on chemically induced liver fibrosis in rats. "
08/01/2012 - "The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation."
08/19/2010 - "Tectorigenin is one of the main components in rhizomes of Iris tectorum, which is traditionally used to treat disorders such as hepatic cirrhosis caused by fibrosis. "
08/01/2012 - "Tectorigenin was also able to inhibit the increase in the liver lipid peroxidation (LPO), as well as the decrease in the activities of liver superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), caused by liver fibrosis. "
|3.||Acute Lung Injury
11/01/2014 - "In this study, the anti-inflammatory effects of tectorigenin on acute lung injury using a lipopolysaccharide (LPS)-induced acute lung injury (ALI) mouse model were investigated The cell-count in the bronchoalveolar lavage fluid (BALF) was measured. "
11/01/2014 - "Tectorigenin inhibits the inflammation of LPS-induced acute lung injury in mice."
|4.||Endometrial Neoplasms (Endometrial Cancer)
05/01/2005 - "The aim of this study was to identify genomic aberrations in endometrial cancer cells treated with the phyto-estrogenic compounds tectorigenin, irigenin and apigenin and to compare with those treated with beta-estradiol using array-based comparative genomic hybridisation (array CGH). "
|5.||Ovarian Neoplasms (Ovarian Cancer)
12/01/2012 - "In this study, we found that tectorigenin, an isoflavonoid isolated from flower of Pueraria thunbergiana, enhanced the growth-inhibitory effect of paclitaxel in paclitaxel-resistant ovarian cancer cells (MPSC1(TR), A2780(TR) and SKOV3(TR)) as well as their naive counterparts. "
12/01/2012 - "These data suggest that tectorigenin could sensitize paclitaxel-resistant human ovarian cancer cells through inactivation of the Akt/IKK/IκB/NFκB signaling pathway, and promise a new intervention to chemosensitize paclitaxel-induced cytotoxicity in ovarian cancer."
12/01/2012 - "Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway."
|1.||Chinese Traditional Medicine (Traditional Chinese Medicine)